![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 21, 19064-19070, May 24, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Biochemistry and Molecular Biology, Penn State University College of Medicine, Hershey, Pennsylvania 17033
Received for publication, November 2, 2001, and in revised form, March 16, 2002
| |
ABSTRACT |
|---|
|
|
|---|
Sedimentation equilibrium studies show that the
Escherichia coli cyclic AMP receptor protein (CAP) and RNA
polymerase holoenzyme associate to form a 2:2 complex in
vitro. No complexes of lower stoichiometry (1:1, 2:1, 1:2) were
detected over a wide range of CAP and RNA polymerase concentrations,
suggesting that the interaction is highly cooperative. The absence of
higher stoichiometry complexes, even in the limit of high [protein],
suggests that the 2:2 species represents binding saturation for this
system. The 2:2 pattern of complex formation is robust. A
lower-limit estimate of the formation constant in our
standard buffer (40 mM Tris (pH 7.9), 10 mM
MgCl2, 0.1 mM dithiothreitol, 5% glycerol, 100 mM KCl) is 2 × 1020
M The Escherichia coli cyclic AMP receptor protein
(CAP1; also known as CRP)
regulates the transcriptional activity of at least 100 promoters
(reviewed in Refs. 1-3). Under conditions of high intracellular
[cAMP], it binds target sequences within or near promoters and
interacts with RNA polymerase holoenzyme to modulate transcription. CAP
is a homodimer with a subunit molecular weight of 23,619 (4). High
resolution crystal structures of CAP-cAMP and CAP-cAMP-DNA complexes
have been obtained (5-8). The CAP-DNA complex is 2-fold symmetric,
with each monomer providing one high affinity binding site for cAMP,
one half of the DNA contacts, and two potential RNA polymerase
interaction surfaces,2
designated activating regions 1 and 2 (3). This polyvalence implies
that it is theoretically possible for CAP to interact with >1 RNA
polymerase molecule at a time.
There is ample precedent for this notion in evidence for regulatory
models in which CAP simultaneously binds two other transcription factors (10), two additional molecules of CAP (11, 12), one additional
transcription factor and RNA polymerase (12, 13), or two RNA polymerase
The E. coli RNA polymerase occurs in two forms, a core
enzyme with subunit composition ( In addition to directing promoter binding and providing a CAP
interaction motif, the Proteins--
E. coli RNA polymerase holoenzyme was
the kind gift of Dr. T. Heyduk. The holoenzyme was prepared by
incubating core enzyme (30) with a 2-fold molar excess of
Sedimentation Equilibrium Assays--
Samples were dialyzed
extensively against 40 mM Tris (pH 7.9), 10 mM
MgCl2, 0.1 mM DTT, 5% glycerol containing
either 100 mM KCl or 300 mM KCl, as indicated.
Aliquots were then centrifuged to equilibrium in a Beckman XL-A
analytical ultracentrifuge equipped with an AN-60 rotor. Absorbance
values were measured at 280 nm as functions of radial position. Five
scans were averaged for each sample at each rotor speed. The approach
to equilibrium was considered to be complete when replicate scans
separated by
At sedimentation equilibrium, the absorbance at a specified wavelength
and position in the solution column is given by Equation 1.
For a system in which monomers (M) are in equilibrium with dimers (D),
Eq. 1 becomes Equation 2.
The Salt-dependent Monomer-Dimer Equilibrium of RNA
Polymerase Holoenzyme--
Both holoenzyme and core RNA polymerases
are known to undergo [salt]-dependent self-association
reactions (26-28, 41, 42). Thus, a characterization of the assembly
states of our samples of RNA polymerase is a prerequisite to the
studies of CAP-polymerase interaction described below. Representative
sedimentation profiles for the RNA polymerase holoenzyme, at 4 °C,
are shown in Fig. 1. Curve
A is a profile obtained at 300 mM KCl; the
solid line through the data is a global least
squares fit of the expression for a single species (Equation 1 with
Curve B is a profile obtained at 100 mM KCl; the solid line through the
data is a global least squares fit of the expression for a
monomer-dimer equilibrium (Equation 2) to nine data sets as described
above. The molecular weight of the monomer was set at 454,000; this
analysis returned an estimate of the association constant
Ka = 7.37 (± 3.55) × 105
M CAP Sediments as a Single, Ideal Species in the Absence of RNA
Polymerase--
Representative sedimentation profiles of CAP, obtained
at 4 °C and 19,000 rpm, are shown in Fig.
2. The solid curves
through the data are global least squares fits of the expression for a single species (Equation 1 with CAP and RNAP Interact in the Absence of
DNA--
Solutions in which CAP and RNA polymerase were combined
contained an additional species with a weight-average molecular weight (~1.1 × 106) significantly greater than that
observed for the RNA polymerase dimer, in the experiments described
above (908,000 ± 12,000). Shown in Fig.
3 are sedimentation equilibrium profiles
acquired from mixtures containing RNA polymerase in slight molar excess (curve A) and CAP in slight molar excess
(curve B). The data were fit by sedimentation
models with two species (Equation 1 with two terms). When RNA
polymerase was in excess (curve A), the model used contained terms for polymerase monomer
(Mr set at 454,000) plus an additional species
(for which Mr was a parameter of the fit). The
molecular weight returned by this analysis was 1,090,000 ± 43,000, consistent with the presence of two equivalents of RNA polymerase monomer in the assembly. The small, uniformly distributed residuals (upper panel) attest to the
compatibility of this model to the data. The three-species model (with
terms for free CAP, RNA polymerase monomer, and a complex) fit the data
as well as the two-species (polymerase + complex) model, but returned
values for the concentration of free CAP that were within error equal to zero (result not shown).4
Other models tested, including that corresponding to the RNA polymerase
monomer-dimer equilibrium, RNA polymerase dimer plus a
complex, and one including terms for free CAP plus a polymerase complex, fit the data less well, as judged by significantly larger
In contrast, when CAP was in slight molar excess over RNA polymerase
(Fig. 3, curve B), the model most consistent with
the data was one that included a term for free CAP and one for an additional species. The molecular weight of the additional component obtained by model fitting to this data set was 1,020,000 ± 57,400, suggesting the presence of two equivalents of RNA polymerase
monomer in the assembly. As before, the small, symmetrical residuals
demonstrate the compatibility of this model with the data. In this
case, three-species models, with terms for CAP, RNA polymerase (either
monomer or dimer), plus a complex fit the data as well as the two-term
(CAP + complex) model, but returned values for the concentration of free RNA polymerase that were within error equal to zero. Other models
tested (one with terms for RNA polymerase monomer and dimer only, one
with terms for free polymerase monomer plus a complex and
one with terms for free polymerase dimer plus a complex), fit the data significantly less well, as judged by large
The CAP:RNA Polymerase Stoichiometry Is 2:2--
The
molecular weights of the CAP-RNA polymerase complex that are returned
by fitting individual data sets suggest that the complex contains two
monomer equivalents of RNA polymerase, but the values lack the
precision needed to specify a unique CAP:RNA polymerase stoichiometry.
Global analysis with NONLIN could not be done, because the current
implementation of that program does not allow modeling of
hetero-associations like that of CAP with RNA polymerase. Analysis of
the dependence of the sum of
To narrow the range of possible stoichiometries, the continuous
variation (Job) method (43) was used to measure the optimal combining
ratio of CAP and RNA polymerase. Seven samples prepared with total
protein fixed ([CAP] + [RNA polymerase] = 7.2 × 10 The 2:2 Pattern of Interaction Is Robust--
Our data suggest
that an overall association mechanism of the type shown by Reaction 1 and Equation 4 operates at 4 °C under our solution conditions (40 mM Tris (pH 7.9), 100 mM KCl, 10 mM MgCl2, 0.1 mM DTT, 5% glycerol).
To ensure that the 2:2 pattern of interaction described above was not
an artifact of our choice of solution conditions, we performed a series
of experiments in which buffer composition, salt concentration,
temperature, and [cAMP] were varied. Shown in Fig.
6 are sedimentation profiles of CAP-RNA
polymerase mixtures brought to equilibrium in buffers containing 300 mM KCl (curve A) and 300 mM potassium glutamate (curve B). The
data shown in curve A were obtained under
conditions of CAP excess; the difference in molecular weights of CAP
dimer (47,238) and 2:2 CAP-polymerase complex (1.0 × 106) accounts for the biphasic character of the curve. The
formation of a complex containing two equivalents of RNA polymerase
under conditions in which the free holoenzyme is monomeric
(c.f. Fig. 1) raises the possibility that CAP binding might
stabilize the dimeric form of polymerase. The data shown in
curve B were obtained under conditions of slight
RNA polymerase excess, and the model fit to the data is that of RNA
polymerase monomer (Mr = 455,000) plus a CAP-polymerase complex. The molecular weight of the complex returned by this analysis is 1,030,000 ± 26,000; this value is most consistent with a 2:2 CAP:polymerase stoichiometry. The formation of similar 2:2 complexes in chloride- and glutamate-containing buffers
suggests that the CAP-polymerase association pattern is not highly
sensitive to the identity of the dominant solution anion.
CAP is a cAMP-dependent transcription activator (1, 44,
45), so it was of interest to determine whether cAMP binding affects
its interaction with the polymerase holoenzyme. Shown in Fig.
7 (curve A) are
data obtained at 4 °C in buffer supplemented with 20 µM cAMP. This concentration of cAMP is sufficient to form the complex containing 1cAMP/CAP dimer that is active in
sequence-specific DNA binding, under conditions of pH and salt
concentration comparable with those used here (35, 46). As shown by the
high quality of the fit, the data are compatible with a two-species
model (RNA polymerase monomer plus a CAP-polymerase
complex). The quality of the fit is not significantly improved by the
inclusion of terms for additional species (result not shown),
indicating that the binding is not weakened by cAMP to the point that
free CAP has become
detectable.6 Analysis using
the two-species model returns a molecular weight estimate for the
complex of 1,070,000 ± 48,000. This is in good agreement with
values obtained in the absence of cAMP and is consistent with the
notion that the association pattern is independent of [cAMP] over the range 0 < [cAMP] < 20 µM.
Kinetic and enzymatic protection studies show that RNA
polymerase-promoter complexes undergo a substantial
temperature-dependent isomerization, corresponding to the
formation of one or more "open" complexes (c.f. Refs.
47-49). To determine whether the CAP-RNA polymerase complex undergoes
a parallel temperature-dependent change in association,
samples were brought to sedimentation equilibrium at 4 (Fig. 3), 10, 20, and 37 °C. Curve B of Fig. 7 shows
representative data obtained at 20 °C. The sample contained a molar
excess of RNA polymerase, so the data were initially analyzed according to the two-species model that includes RNA polymerase
monomer plus a CAP-polymerase complex. The high quality of
the fit indicates that this model is consistent with the data. The
inclusion of terms for additional species did not significantly improve
the fit (result not shown), supporting the notion that additional species are not present in substantial concentration at 20 °C. This
analysis gave a molecular weight for the CAP-polymerase complex of
1,100,000 ± 37,000, compatible with that predicted for a 2:2 complex. Closely similar results were obtained at 10 °C. At 37 °C
a qualitatively similar species distribution is found, but ~30% of
the optical density of samples is lost early in the centrifuge run,
most likely as a consequence of
precipitation7 (results not
shown). Taken together, these results indicate that the 2:2
CAP:polymerase association pattern is maintained over the range
4 °C The results presented above indicate that CAP and RNA polymerase
holoenzyme form a 2:2 complex under quasi-physiological conditions of
[salt], [cAMP], and temperature. The interaction is robust in that
modest changes in these variables do not alter the qualitative pattern
of association. The 2:2 complex is the only CAP-polymerase complex
detected over a wide range (~1000-fold) of protein concentrations and
does not depend on the input CAP:RNA polymerase ratio. The absence of
detectable concentrations of species of lower stoichiometry (e.g. 1:1, 1:2 or 2:1) implies that complex formation is a
cooperative reaction. This notion is reinforced by the observation that
only 2:2 (and not 1:1) complexes are found under solution conditions (300 mM KCl) in which RNA polymerase is monomeric when
sedimented alone. In addition, the absence of higher order complexes,
even under conditions of high [protein], suggests that the 2:2
species represents binding saturation.
Together, these results place stringent limits on possible mechanisms
of association. Both CAP and RNA polymerase have pairs of binding
determinants that interact during the formation of transcription-activation complexes at class I and II promoters (see
above). These determinants are logical candidates for the sites of
protein-protein interaction in the absence of DNA. However, open
polymerization reactions, which are theoretically possible on the basis
of this polyvalence (Fig. 8A),
are not compatible with the absence of 1:1 and 2:1 complexes or the
limiting 2:2 stoichiometry that is observed. Alternative models that
use pairs of binding surfaces and are compatible with a 2:2 limiting
stoichiometry are shown schematically in Fig. 8B. In these
models, surfaces on each CAP monomer (possibly activating region 1 or 2 (Refs. 25 and 50)) interact with complementary surfaces on the
3. The qualitative pattern of association is
unchanged over the temperature range 4 °C
T
20 °C, by substitution of glutamate for chloride as the dominant
anion, or on addition of 20 µM cAMP to the reaction mix.
These results limit the possible mechanisms of CAP-polymerase
association. In addition, they support the idea that CAP binding may
influence the availability of the monomeric form of RNA
polymerase that mediates transcription at many promoters.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
subunits (2, 3). However, these interactions take place when CAP
and its protein partners are DNA-bound and, although CAP has been shown
to interact with polymerase holoenzyme in free solution (14-16), lack
of information about the stoichiometry of these complexes has impeded
their characterization.
)2
'
(Mr ~ 385,000) and a holoenzyme with subunit
composition (
)2
'
(Mr ~ 455,000; reviewed in Refs. 17-19). The
subunit is required for
sequence-specific promoter binding and thus for high fidelity
transcription initiation (20). It also contains a surface motif that
can interact with CAP when the proteins are bound at class II promoters
(3, 21). Two additional motifs that can interact with CAP are located
within the
subunit. The best characterized of these is the "287
determinant" within the COOH-terminal domain of
(3). Mutations of
the residues that comprise this structure interfere with
CAP-dependent transcription activation at class I promoters
(22, 23) and reduce cooperative binding in the formation of CAP-
-DNA
ternary complexes (24). A second motif, located within the
NH2-terminal domain of the
subunit, has been implicated
in CAP interactions at class II and some class III promoters (3, 25).
The multiplicity of CAP-binding motifs indicates single RNA polymerase
molecules have the potential to interact with two or more CAP dimers;
evidence for such interactions at some class III promoters has been
reviewed by Busby and Ebright (3). At present, it is not known whether similar interactions take place in the absence of DNA.
subunit exerts a significant influence on
the self-association pattern of RNA polymerase. The holoenzyme exists
as an equilibrium mixture of monomers and dimers at low salt ([KCl]
300 mM), whereas at higher [salt] the monomer form prevails (Refs. 26 and 27; this study). In contrast, the core enzyme
associates to form complexes at least as large as tetramer, although
the exact mechanism of core enzyme self-association remains controversial (27, 28). Although the biological role of RNA polymerase
self-association is unknown, the observations that the holoenzyme binds
to the lacUV5 promoter as a monomer and to the
tyrT promoter as a dimer have prompted the suggestion that dimerization might influence the distribution of polymerase between available promoters (29). In addition, it is possible that dimerization controls the availability of the holoenzyme form of RNA polymerase, because dimers form preferentially when the
subunit is present (see
above). Because CAP interacts with the RNA polymerase holoenzyme, it
seems plausible that it might modulate the self-association and
functions of RNA polymerase that take place when it is not DNA-bound.
The data presented below represent a first test of this notion.
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
70 (31) and purifying the reconstituted holoenzyme by
MonoQ chromatography (32). By SDS-PAGE and sedimentation equilibrium
criteria, these holoenzyme preparations were fully saturated with
70 (results not shown). The E. coli cyclic
AMP receptor protein was isolated from strain pp47 containing plasmid
pHA5 (kindly provided by Dr. H. Aiba). The purification followed the
protocol of Fried (33) and gave protein of greater than 95% purity as
judged by sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
The preparation used in this study bound 10 nmol of cAMP/mg of protein
in the cAMP binding assay of Anderson et al. (34) and was
~80% active in cAMP-dependent binding to the
lac promoter, according to the method of Fried and Crothers
(35). Protein concentrations were determined spectrophotometrically
using
280 = 2.82 × 105
M
1 cm
1/RNAP holoenzyme monomer
(18) and
280 = 3.5 × 104
M
1 cm
1/CAP dimer (34).
8 h were indistinguishable.
Here A(r) is the absorbance at radial
position r, the summation is over all species, n;
(Eq. 1)
n,0 is the absorbance of the nth
species at the reference position r0,
n = Mn(1

)
2/2RT
with Mn the molecular weight of the
nth species,

the solution density,
the rotor angular velocity,
R the gas constant, and T the absolute temperature. Buffer densities were measured with a Mettler density meter. The base-line offset term
compensates for slight
position-independent differences in the optical properties of different
cell assemblies.
Here
(Eq. 2)
D = 2MM(1

)
2/2RT
and the absorbance term for dimer depends on the absorbance scale
association constant,
D,0 = K'(
M,0)2. Association constants
were estimated by simultaneous least squares fitting of Equation 2 to
multiple data sets ("global analysis") using the program
NONLIN,3 running on a
Macintosh computer (38). Typical analyses used nine data sets
corresponding to three samples differing in nominal protein
concentration, centrifuged at three rotor speeds.
2 Analysis of Molecular Weights--
Our current
implementation of the global analysis program NONLIN allows the
modeling of self-association reactions but not hetero-associations like
that of CAP with RNA polymerase. To circumvent this limitation, we fit
single data sets to hetero-association models, testing several fixed
values of the molecular weights of the CAP-polymerase complex. The
molecular weight value that minimizes the
2 parameter
(Equation 3; Ref. 39) is the "best" estimate, by the least-squares criterion.
Here the summation is over radial positions r, the
observed absorbance is Ar, the standard
deviation in Ar is
(Eq. 3)
r, and the absorbance predicted by the fit is A(r).
A valuable feature of the
2 parameter is that it is
additive. Thus, the sum of
2 values obtained from
fitting different individual data sets (with the same binding equation)
is itself a
2 parameter (40). The molecular weight that
minimizes this sum of
2 parameters is the value most
consistent with the data by this "global" criterion.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
n corresponding to RNA polymerase
monomer) to nine data sets (three concentrations, three
rotor speeds). The small, symmetrically distributed curve-fitting residuals demonstrate the compatibility of the single-species model
with the data. The value of Mr (± 67%
confidence interval) returned by this analysis was 454,000 ± 6,000, in good agreement with the value of the monomer molecular weight
(4.55 × 105) predicted on the basis of the subunit
composition (
2
'
) of the holoenzyme (18, 27).
This molecular weight and the small confidence interval demonstrate
that the enzyme is
-saturated. In addition, these values are
incompatible with significant self-association or degradation in our
samples under these experimental conditions.

View larger version (30K):
[in a new window]
Fig. 1.
Sedimentation equilibrium analyses of RNA
polymerase holoenzyme. Representative data were obtained at
4 °C in buffers consisting of 40 mM Tris (pH 7.9), 10 mM MgCl2, 0.1 mM DTT, 5% glycerol,
and 300 mM KCl (curve A) or 100 mM KCl (curve B). Sample A
was centrifuged at 9,000 rpm; the data are offset by 0.1 absorbance
unit for clarity. The smooth curve is the global fit of the ideal
single-species model (Equation 1 with a single term) as described under
"Materials and Methods." The value of Mr
returned by this analysis was 454,000 ± 6,000. Sample
B was centrifuged at 7,000 rpm. The smooth curve is the
global fit of the monomer-dimer model (Equation 2), with monomer
molecular weight set at 454,000 as described under "Materials and
Methods." In both cases the curve-fitting residuals (upper
panels) are small and lack obvious systematic dependence on
radial position, demonstrating that the corresponding models are
consistent with the mass distributions present in these samples.
1. The small values of the residuals and
lack of obvious systematic dependence on radial position indicate that
the monomer-dimer model is consistent with the data from these samples
and argue strongly against the presence of higher molecular weight
assemblies under these solution conditions. These results are in
excellent agreement with those of Record and co-workers (27), who found a monomer-dimer association with an apparent association constant of
~106 M
1 under similar ionic conditions.
n
corresponding to CAP) to six data sets (two concentrations, three rotor
speeds). The small, symmetrically distributed residuals demonstrate the
compatibility of the single-species model with the data. The molecular
weights returned by these analyses were 48,400 ± 1,400 for CAP in
buffer containing 300 mM KCl (curve
A) and 47,800 ± 1,400 for CAP in buffer containing 100 mM KCl (curve B). The agreement with
the molecular weight derived from sequence (Mr
(CAP dimer) = 47,238) indicates that this protein is neither
degraded nor aggregated under our experimental conditions.

View larger version (32K):
[in a new window]
Fig. 2.
Sedimentation equilibrium analyses of CAP
protein. Representative data were obtained at 4 °C in buffers
consisting of 40 mM Tris (pH 7.9), 10 mM
MgCl2, 0.1 mM DTT, 5% glycerol, and
300 mM KCl (curve A) or 100 mM KCl (curve B). Both samples were
centrifuged at 19,000 rpm; the data of curve A
are offset by 0.1 absorbance unit for clarity. The smooth curves are
global fits of the ideal single-species model (Equation 1 with a single
term) as described under "Materials and Methods." The values of
Mr returned by this analysis were: 48,400 ± 1,400 for CAP in 300 mM KCl (curve
A) and 47,800 ± 1,400 for CAP in 100 mM
KCl (curve B). The curve-fitting residuals are
shown in the upper panels.
2 values and evidence of systematic dependence of
residuals on radial position (results not shown).

View larger version (31K):
[in a new window]
Fig. 3.
CAP and RNAP interact in the absence of
DNA. Representative data were obtained under conditions of RNA
polymerase excess (curve A) and CAP excess
(curve B). In both cases, the binding buffer
contained 40 mM Tris (pH 7.9), 10 mM
MgCl2, 0.1 mM DTT, 5% glycerol, and 100 mM KCl; both data sets were obtained at 4 °C and 5,000 rpm. Bottom panel, sample A contained
2.7 × 10
7 M CAP and 4.5 × 10
7 M RNA polymerase. The smooth curve is
the fit to the two-species model (free RNA polymerase monomer plus a
CAP-polymerase complex) to the data set. The molecular weight of the
complex returned by this analysis was 1,090,000 ± 43,000. Sample
B contained 3.6 × 10
7 M CAP
and 3.2 × 10
7 M RNA polymerase. The
smooth curve is the fit to the two-species model (free CAP plus
CAP-polymerase complex) to the data set. The molecular weight of the
complex returned by this analysis was 1,020,000 ± 57,400. The
fitting residuals are shown in the upper
panels.
2 values and evidence of systematic dependence of
residuals on radial position (results not shown).
2 values on molecular
weight of the complex for ensembles of data sets (nine in which CAP was
in molar excess and nine with RNA polymerase in excess) revealed broad
minima centered at Mr(complex) = 1 × 106 (Fig. 4). Although this
value is most consistent with a 2:2 stoichiometry, the broad
distributions do not rule out 2:1 and 2:3 molar ratios.

View larger version (14K):
[in a new window]
Fig. 4.
Global dependence of
2 on the molecular weight of the CAP-polymerase
complex. Each curve represents the analysis of nine data sets,
corresponding to three protein concentrations and three rotor speeds.
, data obtained under conditions of RNA polymerase molar excess;
, data obtained under conditions of CAP molar excess, offset by
+0.01 absorbance unit for clarity. Each data set was fit using the
version of Equation 1 corresponding to the appropriate model (free CAP + complex in samples with excess CAP, free RNA polymerase monomer + complex in samples with excess polymerase), but with the molecular
weight of the complex held constant. The sum of
2 values
from these fits is a measure of the deviation of the model from the
data ensemble (39, 40). Varying the input value of the molecular weight
of the complex yields a distribution of summed
2 values;
the minimum value is the global least-squares best estimate of the
molecular weight. Both
2 distributions are minimized
near Mr(complex) = 1 × 106.
7 M), but ranging in mole fraction of CAP
from 0 to 1, gave values of Mr (complex)
compatible with a 2:2 molar ratio (mean ± S.D. = 1,060,000 ± 52,000; Fig. 5). In addition, the
amount of complex observed depended on the mole fraction of CAP, giving
a maximum when the mole fraction of CAP = 0.5 (equivalent to a
molar ratio of 1 CAP/RNA polymerase). Together, these results support
the notion that the complex has a 2:2 stoichiometry. The preferential formation of 2:2 complex and the absence of complexes of other stoichiometries (e.g. CAP:polymerase = 1:2 under
conditions of polymerase excess, or CAP:polymerase = 2:1 under
conditions of CAP excess) strongly suggests that the binding of CAP to
RNA polymerase is cooperative. Further, the absence of detectable
amounts of complex of higher molecular weight indicates that
association does not proceed beyond the 2:2 ratio.

View larger version (19K):
[in a new window]
Fig. 5.
Continuous variation (Job) plot
showing that the optimal combining ratio is 1:1. Lower
panel, dependence of normalized [complex] (± 95%
confidence limits) on mole fraction of CAP. The total protein
concentration was fixed ([CAP] + [RNA polymerase] = 7.2 × 10
7 M), but the mole fraction was allowed to
vary as indicated. The binding buffer was 40 mm Tris (pH 7.9), 10 mM MgCl2, 0.1 mM DTT, 5% glycerol,
100 mM KCl. Individual data sets were fit using two-species
models; under conditions of CAP molar excess, the model corresponded to
free CAP plus a complex, under conditions of RNA polymerase excess, the
model corresponded to free polymerase monomer plus a complex.
Upper panel, the molecular weights (± 95%
confidence limits) returned by these analyses. The
horizontal line indicates the molecular weight
expected for a 2:2 CAP-polymerase complex (Mr = 1.00 × 106).
This pattern is valid over a wide range of protein concentrations.
For a typical experiment in which RNA polymerase binds half of the
available CAP, we estimate5
that the free CAP concentrations range from the detection limit (A280 ~ 0.002 = 5 × 10
(Eq. 4)
8 M) near the meniscus to ~6 × 10
6 M near the bottom of the centrifuge cell.
Similarly, in an RNA polymerase-excess experiment in which CAP is
half-saturating, we estimate that 6 × 10
9
M
[RNA polymerase]
1.5 × 10
6
M. Because no free CAP can be detected in a
polymerase-excess experiment, [CAP]free must be <5 × 10
8 M under these conditions. Taken
together, the lower limit of [CAP]free and the upper
limit of [RNA polymerase]free provide us with a
lower-limit estimate for the formation constant,
Ka
2 × 1020
M
3. With several caveats (discussed below),
this formation constant is compatible with previous in vitro
estimates of the apparent association constant for CAP with RNA
polymerase holoenzyme, in the absence of DNA.

View larger version (30K):
[in a new window]
Fig. 6.
CAP and RNA polymerase holoenzyme form 2:2
complexes in solutions containing 300 mM potassium chloride
and 300 mM potassium glutamate. Representative data
were obtained at 7,000 rpm and 4 °C in buffers containing 40 mM Tris (pH 7.9), 10 mM MgCl2, 0.1 mM DTT, 5% glycerol, and 300 mM KCl
(curve A) or 300 mM potassium
glutamate (curve B). Bottom
panel, sample A contained 4.9 × 10
7 M CAP and 3.3 × 10
7
M RNA polymerase. The smooth curve is the fit to the
two-species model (free CAP plus a CAP-polymerase complex) to the data
set. The molecular weight of the complex returned by this analysis was
1,010,000 ± 47,000. Sample B contained 3.2 × 10
7 M CAP and 3.8 × 10
7
M RNA polymerase. The smooth curve is the fit to the
two-species model (free RNA polymerase monomer plus
CAP-polymerase complex) to the data set. The molecular weight of the
complex returned by this analysis was 1,030,000 ± 26,000. The
small, symmetrical residuals (upper panels)
attest to the compatibility of these models with the data.

View larger version (31K):
[in a new window]
Fig. 7.
Effects of cAMP and elevated temperature on
binding. Curve A, binding in the presence of
20 µM cAMP. Representative data obtained at 4 °C in 40 mM Tris (pH 7.9), 10 mM MgCl2, 0.1 mM DTT, 5% glycerol, 100 mM KCl, 20 µM cAMP. The sample contained 3.7 × 10
7 M CAP and 3.8 × 10
7
M RNA polymerase; the data were fit by the two-species
model that includes RNA polymerase monomer plus a
CAP-polymerase complex. The molecular weight returned for the complex
was 1,070,000 ± 48,000. Curve B, data
obtained at 20 °C in 40 mM Tris (pH 7.9), 10 mM MgCl2, 0.1 mM DTT, 5% glycerol,
100 mM KCl buffer. The sample contained 3.7 × 10
7 M CAP and 4.5 × 10
7
M RNA polymerase; the data were fit by the two-species
model that includes RNA polymerase monomer plus a CAP-polymerase
complex. The molecular weight returned for the complex was
1,100,000 ± 37,000.
T
20 °C and that it may extend to
somewhat higher temperatures.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
subunit of RNA polymerase.8
We envision two arrangements, one in which each CAP dimer binds the
pair of
subunits on a single polymerase monomer (a cis
configuration) and one in which each CAP dimer bridges between
subunits on two polymerase monomers (a "trans " configuration). We currently favor the trans configuration
because cross-bridging between polymerase monomers has the potential to
stabilize a polymerase dimer, and dimer stabilization by the first CAP
molecule has the potential to account for the cooperative binding of a
second CAP molecule. These effects are not available in the
cis configuration.

View larger version (23K):
[in a new window]
Fig. 8.
Schematic models of CAP-RNA polymerase
association. A, a hypothetical open
polymerization mechanism that is compatible with the polyvalent
characters of CAP and RNA polymerase. RNA polymerase
(magenta) and CAP (blue) assemble in alternation.
The carboxyl-terminal domains of RNA polymerase
subunits are
labeled (
). This pattern allows 1:1, 1:2, and 2:1
stoichiometries as well as stoichiometries greater than 2:2. The data
presented in this paper argue against mechanisms of this kind.
B, hypothetical 2:2 complexes in which CAP dimers
(blue) bridge between adjacent
subunits
(
). Left and center
drawings represent the trans configuration, in
which CAP bridges between
subunits of different RNA polymerase
monomers. The right drawing represents a
cis configuration in which CAP bridges between
subunits
of the same polymerase monomer.
Our data allow us to obtain a lower limit
estimate of the formation constant for the CAP-polymerase complex,
Ka
2 × 1020
M
3. Several attempts to measure the stability
of CAP-polymerase complexes predate this report, but all have depended
on the assumption of a 1:1 stoichiometry and thus yield estimates of a
"monomer-equivalent" association constant
(Kapparent,1:1). In 1980, Blazy and co-workers (14) used non-equilibrium sucrose-gradient centrifugation to obtain
Kapparent,1:1 ~ 3.3 × 105
M
1 in the presence of cAMP. Parallel
experiments carried out in the absence of cAMP failed to detect
binding, although this may be ascribable to the non-equilibrium nature
of their assay. Later, Pinkney and Hoggett (15) used fluorescence
polarization measurements with fluorescein-labeled CAP to obtain a
monomer-equivalent estimate Kapparent,1:1 ~ 3.3 × 105 M
1 in the
presence of cAMP. Most recently, Heyduk and colleagues (16) used the
fluorescence polarization of a fluorescein-labeled 42-bp CAP binding
site DNA to monitor the formation of a DNA-CAP-RNA polymerase ternary
complex, from which they obtained the estimate Kapparent,1:1:1 ~ 3.5 × 106
M
1 in the presence of cAMP. Because of the
presence of DNA, it is not clear that the latter interaction follows
the same mechanism as the one described here. However, assuming that
all studies characterized the same interaction, and assuming equal CAP
and RNA polymerase concentrations, the previously reported
Kapparent,1:1 values predict formation constants
for the 2:2 complex in the range 3.6 × 1016
M
3
Ka
4.3 × 1019 M
3. Given the differences in
solution conditions and possible differences in the activities of
protein preparations, these values are in reasonable agreement with our
lower-limit estimate of the formation constant.
The in vitro self-association of RNA polymerase has been
studied intermittently since 1966 (26-28, 41, 42, 51), with later
studies gaining impetus from the suggestion (29) that dimerization
might play a transcription-regulatory role by influencing the
distribution of RNA polymerase between competing promoters. Here we
have shown that CAP binds preferentially to the dimeric form of
polymerase holoenzyme. This implies that CAP stabilizes the polymerase
dimer, although this conclusion comes with a caveat, because the
sedimentation equilibrium data provide no information about the
arrangement of molecules within the CAP-polymerase complex. Thus, we
cannot yet say whether the polymerase-interactions that form the dimer
in free solution are identical to those present when CAP is bound.
Similarly, we are not yet in a position to say whether CAP-polymerase
complexes of the kind investigated here form in vivo.
Nonetheless, these results open to future investigation the intriguing
possibility that CAP might regulate functions of the RNA polymerase
holoenzyme that take place prior to promoter binding.
| |
ACKNOWLEDGEMENT |
|---|
We are grateful to Dr. Tomasz Heyduk for providing the RNA polymerase used in these studies.
| |
FOOTNOTES |
|---|
* This work was supported by grants from the Penn State University Life Science Consortium (to M. G. F. and D. D.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Biochemistry
and Molecular Biology, Penn State University College of Medicine,
P .O. Box 850, Hershey, PA 17033. Tel.: 717-531-5250; Fax:
717-531-7072; E-mail: mfried@psu.edu.
Published, JBC Papers in Press, March 19, 2002, DOI 10.1074/jbc.M110554200
2 A third non-native activating region (activating region 3, residues 52-58) is created by substitution of Lys-52 by a neutral or negatively charged residue (3, 9).
3 NONLIN for the Macintosh was obtained from the software archive located in the Reversible Associations in Structural and Molecular Biology web site (www.bbri.org/RASMB/rasmb.html).
4 As discussed below, this result suggests that the formation constant for the CAP-RNA polymerase complex may be quite large.
5 This is based on data obtained at 7,000 rpm and 4°C, in our standard buffer, 40 mM Tris (pH 7.9), 100 mM KCl, 10 mM MgCl2, 0.1 mM DTT, 5% glycerol.
6 Although this prevents any conclusion about whether cAMP alters the stability of the CAP-polymerase interaction, it is also incompatible with a large destabilization of the complex.
7 SDS-polyacrylamide gel electrophoresis analyses of recovered samples confirm that this apparent precipitation was not accompanied by proteolytic degradation.
8
These models are offered as a working hypothesis
with the acknowledgement that other patterns of interaction, including
ones that use the
subunit CAP determinant and/or monovalent
CAP-polymerase interactions, are also compatible with the data.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: CAP, cyclic AMP receptor protein; RNAP, RNA polymerase; DTT, dithiothreitol.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Kolb, A., Busby, S., Buc, H., Garges, S., and Adhya, S. (1993) Annu. Rev. Biochem. 62, 749-796[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Savery, N., Rhodius, V., and Busby, S. (1996) Philos. Trans. R. Soc. Lond. B Biol. Sci. 351, 543-550[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Busby, S., and Ebright, R. H. (1999) J. Mol. Biol. 293, 199-213[CrossRef][Medline] [Order article via Infotrieve] |
| 4. |
Aiba, H.,
Fugimoto, S.,
and Ozaki, N.
(1982)
Nucleic Acids Res.
10,
1345-1361 |
| 5. |
McKay, D. B.,
Weber, I. T.,
and Steitz, T. A.
(1982)
J. Biol. Chem.
257,
9518-9524 |
| 6. |
Schultz, S.,
Shields, G.,
and Steitz, T.
(1991)
Science
253,
1001-1007 |
| 7. | Parkinson, G., Wilson, C., Gunasekera, A., Ebright, Y., Ebright, R., and Berman, H. (1996) J. Mol. Biol. 260, 395-408[CrossRef][Medline] [Order article via Infotrieve] |
| 8. | Passner, J., and Steitz, T. (1998) Proc. Natl. Acad. Sci. U. S. A. 94, 2843-2847 |
| 9. |
Bell, A.,
Gaston, K.,
Williams, R.,
Chapman, K.,
Kolb, A.,
Buc, H.,
Minchin, S.,
Williams, J.,
and Busby, S.
(1990)
Nucleic Acids Res.
18,
7243-7250 |
| 10. |
Nasser, W.,
Schneider, R.,
Travers, A.,
and Muskhelishvili, G.
(2001)
J. Biol. Chem.
276,
17878-17886 |
| 11. | Ramseier, T. M., and Saier, M. H., Jr. (1995) Microbiology 141, 1901-1907[Abstract] |
| 12. | Richet, E. (2000) EMBO J. 19, 5222-5232[CrossRef][Medline] [Order article via Infotrieve] |
| 13. |
Johnson, C. M.,
and Schleif, R. F.
(2000)
J. Bacteriol.
182,
1995-2000 |
| 14. | Blazy, B., Takahashi, M., and Baudras, A. (1980) Mol. Biol. Rep. 6, 39-43[CrossRef][Medline] [Order article via Infotrieve] |
| 15. | Pinkney, M., and Hoggett, J. (1988) Biochem. J. 250, 897-902[Medline] [Order article via Infotrieve] |
| 16. | Heyduk, T., Lee, J. C., Ebright, Y. W., Blatter, E. E., Zhou, Y., and Ebright, R. H. (1993) Nature 364, 548-549[CrossRef][Medline] [Order article via Infotrieve] |
| 17. | Chamberlin, M. (1976) in RNA Polymerase (Losick, R. , and Chamberlin, M., eds) , pp. 17-67, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY |
| 18. | Burgess, R. (1976) in RNA Polymerase (Losick, R. , and Chamberlin, M., eds) , pp. 69-100, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY |
| 19. | von Hippel, P., Yager, T., and Gill, S. (1992) in Transcriptional Regulation (McKnight, S. , and Yamamoto, K., eds) , pp. 179-201, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY |
| 20. | Chamberlin, M. J. (1976) in RNA Polymerase (Losick, R. , and Chamberlin, M. J., eds) , pp. 159-191, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY. |
| 21. |
Jin, R.,
Sharif, K. A.,
and Krakow, J. S.
(1995)
J. Biol. Chem.
270,
19213-19216 |
| 22. | Zou, C., Fujita, N., Igarishi, K., and Ishihama, A. (1992) Mol. Microbiol. 6, 2599-2605[CrossRef][Medline] [Order article via Infotrieve] |
| 23. |
Tang, H.,
Severinov, K.,
Goldfarb, A.,
Fenyo, D.,
Chait, B.,
and Ebright, R. H.
(1994)
Genes Dev.
8,
3058-3067 |
| 24. | Savery, N., Lloyd, G., Kainz, M., Gaal, T., Ross, W., Ebright, R., Gourse, R., and Busby, S. (1998) EMBO J. 17, 3439-3447[CrossRef][Medline] [Order article via Infotrieve] |
| 25. | Niu, W., Kim, Y., Tau, G., Heyduk, T., and Ebright, R. H. (1996) Cell 87, 1123-1134[CrossRef][Medline] [Order article via Infotrieve] |
| 26. | Pilz, I., Kratky, O., and Rabussay, D. (1972) Eur. J. Biochem. 28, 205-220[CrossRef][Medline] [Order article via Infotrieve] |
| 27. | Shaner, S. L., Piatt, D. M., Wensley, C. G., Yu, H., Burgess, R. R., and Record, M. T., Jr. (1982) Biochemistry 21, 5539-5551[CrossRef][Medline] [Order article via Infotrieve] |
| 28. | Harris, S. J., Williams, R. C., Jr., and Lee, J. C. (1995) Biochemistry 34, 8752-8762[CrossRef][Medline] [Order article via Infotrieve] |
| 29. |
Travers, A. A.,
Lamond, A. I.,
and Mace, H. A.
(1982)
Nucleic Acids Res.
10,
5043-5057 |
| 30. | Burgess, R. R., and Jendrisak, J. (1975) Biochemistry 14, 4634-4638[CrossRef][Medline] [Order article via Infotrieve] |
| 31. | Callaci, S., and Heyduk, T. (1998) Biochemistry 37, 3312-3320[CrossRef][Medline] [Order article via Infotrieve] |
| 32. | Hager, D. A., Jin, D. J., and Burgess, R. R. (1990) Biochemistry 29, 7890-7894[CrossRef][Medline] [Order article via Infotrieve] |
| 33. | Fried, M. (1982) On the Interactions of the Escherichia coli Cyclic AMP Receptor and lac Repressor with DNA.Ph.D. dissertation , Yale University, New Haven, CT |
| 34. |
Anderson, W. B.,
Schneider, A. B.,
Emmer, M.,
Perlman, R. L.,
and Pastan, I.
(1971)
J. Biol. Chem.
246,
5929-5937 |
| 35. | Fried, M. G., and Crothers, D. M. (1984) J. Mol. Biol. 172, 241-262[Medline] [Order article via Infotrieve] |
| 36. |
Fried, M. G.,
and Daugherty, M. A.
(2001)
J. Biol. Chem.
276,
11226-11229 |
| 37. |
Burgess, R. R.
(1969)
J. Biol. Chem.
244,
6160-6167 |
| 38. |
Johnson, M. L.,
Correia, J. J.,
Yphantis, D. A.,
and Halvorson, H. R.
(1981)
Biophys. J.
36,
575-588 |
| 39. | Bevington, P. R., and Robinson, D. K. (1992) Data Reduction and Error Analysis for the Physical Sciences , 2nd Ed. , McGraw-Hill, Inc., New York |
| 40. | Bailey, N. T. J. (1981) Statistical Methods in Biology , 2nd Ed. , Hodder and Stoughton, London |
| 41. | Berg, D., and Chamberlin, M. (1970) Biochemistry 9, 5055-5064[CrossRef][Medline] [Order article via Infotrieve] |
| 42. | Shaner, S. L., Melançon, P., Lee, K. S., Burgess, R. R., and Record, M. T., Jr. (1983) Cold Spring Harbor Symp. Quant. Biol. 47, 463-472[Medline] [Order article via Infotrieve] |
| 43. | Huang, C. Y. (1982) Methods Enzymol. 87, 509-525[Medline] [Order article via Infotrieve] |
| 44. |
deCrombrugghe, B.,
Busby, S.,
and Buc, H.
(1984)
Science
224,
831-838 |
| 45. |
Adhya, S.,
and Garges, S.
(1990)
J. Biol. Chem.
265,
10797-10800 |
| 46. | Hudson, J. M., Crowe, M., and Fried, M. G. (1993) Eur. J. Biochem. 212, 539-548[Medline] [Order article via Infotrieve] |
| 47. | Roe, J. H., and Record, M. T. (1985) Biochemistry 24, 4271-4276 |
| 48. | Straney, D. C., and Crothers, D. M. (1985) Cell 43, 449-459[CrossRef][Medline] [Order article via Infotrieve] |
| 49. | Spassky, A., Kirkegaard, K., and Buc, H. (1985) Biochemistry 24, 2723-2731[CrossRef][Medline] [Order article via Infotrieve] |
| 50. | Ebright, R. H. (1993) Mol. Microbiol. 8, 797-802[Medline] [Order article via Infotrieve] |
| 51. |
Richardson, J. P.
(1966)
Proc. Natl. Acad. Sci. U. S. A.
55,
1616-1623 |